The phosphatase SHIP2 has been the focus of drug development efforts for diabetes. This distinction is based in part on work suggesting that the molecule is central to the regulation of glucose levels in tissues and blood. An analysis of a SHIP2 knockout mouse changes this viewpoint and provides new directions for therapeutic intervention (pages 199–205).
This is a preview of subscription content, log in via an institution to check access.
Kimberly Caesar
References
Sleeman, M.W., Wortley, K.E., Lai, K.-M., Gowen, L.C. & Kinter, J. Nat. Med. 11, 199–205 (2005).
Saltiel, A.R. & Kahn, C.R. Nature 414, 799–806 (2001).
Fruman, D.A., Meyers, R.E. & Cantley, L.C. Annu. Rev. Biochem. 67, 481–507 (1998).
Maehama, T. & Dixon, J.E. Trends Cell Biol. 9, 125–128 (1999).
Pesesse, X., Deleu, S., De Smedt, F., Drayer, L. & Erneux, C. Biochem. Biophys. Res. Commun. 239, 697–700 (1997).
Habib, T., Hejna, J.A., Moses, R.E. & Decker, S.J. J. Biol. Chem. 273, 18605–18609 (1998).
Clement, S. et al. Nature 409, 92–97 (2001).
Clement S. et al. Nature 431, 878 (2004).
Nandi, A., Kitamura, Y., Kahn, C.R. & Accili, D. Physiol. Rev. 84, 623–647 (2004).
Um, S.H. et al. Nature 431, 200–205 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Decker, S., Saltiel, A. Staying in SHIP shape. Nat Med 11, 123–124 (2005). https://doi.org/10.1038/nm0205-123
Issue Date:
DOI: https://doi.org/10.1038/nm0205-123
- Springer Nature America, Inc.